Phase 2 study of cryptophycin 52 (LY355703) in patients previously treated with platinum based chemotherapy for advanced non-small cell lung cancer

Martin J. Edelman, David R. Gandara, Petr Hausner, Valerie Israel, Donald Thornton, Jennifer DeSanto, L. Austin Doyle

Research output: Contribution to journal › Article › peer-review

78 Scopus citations

Fingerprint

Dive into the research topics of 'Phase 2 study of cryptophycin 52 (LY355703) in patients previously treated with platinum based chemotherapy for advanced non-small cell lung cancer'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science